72 kDa type IV collagenase
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 115–213 Chain A; UniProt 394–449 | Fragment:CATALYTIC DOMAIN RESIDUES 88-250 WITH THE FIBRONECTIN DOMAIN DELETED | ZN ZINC ION × 2 CA CALCIUM ION × 3 | X-RAY DIFFRACTION X-ray crystallization conditions:pH 6;pH 6.0 | Resolution 2.80 Å R-free 0.244 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1QIB | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1CK7 GELATINASE A (FULL-LENGTH) Deposited 1999-04-28 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
30–660(631 aa)
Fragment:FULL-LENGTH
|
Mutation:E404A | ZN ZINC ION × 2 CA CALCIUM ION × 3 CL CHLORIDE ION × 1 NA SODIUM ION × 1 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.8;pH 7.8
|
Resolution 2.80 Å R-free 0.327 |
| 1CXW THE SECOND TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2 Deposited 1999-08-31 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
278–336(59 aa)
Fragment:THE SECOND TYPE II MODULE
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.2;298 K;Ionic strength (raw mmCIF value) 0;Pressure 1
NMR measurement conditions
pH 5.1;298 K;Ionic strength (raw mmCIF value) 0;Pressure 1
NMR sample composition
1.3MM COL-2 NA; 90% H2O, 10% D2O
NMR sample composition
1.3MM COL-2 NA; D2O
NMR sample composition
1MM COL-2 U-15N; 90% H2O, 10% D2O
NMR sample composition
4MM COL-2 U-15N; 90% H2O, 10% D2O
|
Resolution not provided |
| 1EAK Catalytic domain of proMMP-2 E404Q mutant Deposited 2001-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
32–452(421 aa)
Fragment:CATALYTIC DOMAIN RESIDUES 32-452
Chain C
32–452(421 aa)
Fragment:CATALYTIC DOMAIN RESIDUES 32-452
|
Mutation:YES Mutation:YES | SO4 SULFATE ION × 3 ZN ZINC ION × 4 CA CALCIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;PH 8.50
|
Resolution 2.66 Å R-free 0.303 |
| 1EAK Catalytic domain of proMMP-2 E404Q mutant Deposited 2001-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
32–452(421 aa)
Fragment:CATALYTIC DOMAIN RESIDUES 32-452
Chain D
32–452(421 aa)
Fragment:CATALYTIC DOMAIN RESIDUES 32-452
|
Mutation:YES Mutation:YES | SO4 SULFATE ION × 3 ZN ZINC ION × 4 CA CALCIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;PH 8.50
|
Resolution 2.66 Å R-free 0.303 |
| 1GEN C-TERMINAL DOMAIN OF GELATINASE A Deposited 1995-07-19 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
443–660(218 aa)
Fragment:C-TERMINAL DOMAIN
|
Not recorded | ZN ZINC ION × 1 CA CALCIUM ION × 1 CL CHLORIDE ION × 1 NA SODIUM ION × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.15 Å R-free 0.260 |
| 1GXD proMMP-2/TIMP-2 complex Deposited 2002-04-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
30–660(631 aa)
|
Mutation:YES | SO4 SULFATE ION × 1 ZN ZINC ION × 2 CA CALCIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.50
|
Resolution 3.10 Å R-free 0.333 |
| 1GXD proMMP-2/TIMP-2 complex Deposited 2002-04-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
30–660(631 aa)
|
Mutation:YES | SO4 SULFATE ION × 1 ZN ZINC ION × 2 CA CALCIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.50
|
Resolution 3.10 Å R-free 0.333 |
| 1HOV SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020 Deposited 2000-12-11 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
110–256(147 aa)
Fragment:CATALYTIC DOMAIN
|
Not recorded | ZN ZINC ION × 2 CA CALCIUM ION × 2 I52 N-{4-[(1-HYDROXYCARBAMOYL-2-METHYL-PROPYL)-(2-MORPHOLIN-4-YL-ETHYL)-SULFAMOYL]-4-PENTYL-BENZAMIDE × 1 |
SOLUTION NMR
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 50;Pressure 1
NMR sample composition
0.3-0.4mM U-15N, 13C MMP-2C: unlabeled SC-74020 in 20mM TRIS-d11-HCl, 5mM CaCl2, 10uM ZnCl2, 20uM unlabeled SC-74020 | 90% H2O/10% D2O
|
Resolution not provided |
| 1J7M The Third Fibronectin Type II Module from Human Matrix Metalloproteinase 2 Deposited 2001-05-17 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
337–394(58 aa)
Fragment:third fibronectin type II module
|
Mutation:E11G | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.4;298 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition
0.5mM col-3 NA; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5mM col-3 NA; D2O | D2O
NMR sample composition
1mM col-3 U-15n; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 1KS0 The First Fibronectin Type II Module from Human Matrix Metalloproteinase 2 Deposited 2002-01-10 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
223–282(60 aa)
Fragment:First Fibronectin Type II Module
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.3;298 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR measurement conditions
pH 6;298 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition
0.5mM col-1; 90% H2O, 10% d6-acetone | 90% H2O, 10% d6-acetone
NMR sample composition
0.5mM col-1; 90% D2O, 10% d6-acetone | 90% D2O, 10% d6-acetone
NMR sample composition
0.7mM col-1 15N; 90% H2O, 10% d6-acetone | 90% H2O, 10% d6-acetone
|
Resolution not provided |
| 1RTG C-TERMINAL DOMAIN (HAEMOPEXIN-LIKE DOMAIN) OF HUMAN MATRIX METALLOPROTEINASE-2 Deposited 1995-12-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
451–660(210 aa)
Fragment:C-TERMINAL RESIDUES 451 - 660, HAEMOPEXIN-LIKE DOMAIN
|
Not recorded | CL CHLORIDE ION × 1 CA CALCIUM ION × 2 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.60 Å |
| 3AYU Crystal structure of MMP-2 active site mutant in complex with APP-drived decapeptide inhibitor Deposited 2011-05-17 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
110–219(110 aa)
Fragment:UNP residues 110-219 and 394-450
Chain A
394–450(57 aa)
Fragment:UNP residues 110-219 and 394-450
|
Mutation:E108K, Q110V, E121A Mutation:E108K, Q110V, E121A | ZN ZINC ION × 2 CA CALCIUM ION × 3 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.00 Å R-free 0.205 |
10 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | MMP2_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–99; UniProt 115–213 Author chain A; PDBConstruct 106–161; UniProt 394–449 |